Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC on ephedra

This article was originally published in The Tan Sheet

Executive Summary

FTC considers claims ephedra products are safe to be misleading and "we can and do go to federal court in order to stop" them, Bureau of Consumer Protection Director Howard Beales tells House Government Reform Committee March 27 during Internet pharmacy hearing. In response to question from Rep. Henry Waxman (D-Calif.), Beales states FTC has filed "four cases so far going back to 1997 challeng[ing] claims that ephedra was safe or had no side effects as unsubstantiated." He notes all four cases were decided in FTC's favor and that "we have other investigations involving ephedra products and there will be more cases that are in the pipeline"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095284

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel